KAVL Fundamental Analysis - KAIVAL BRANDS INNOVATIONS GR

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to KAVL. KAVL was compared to 22 industry peers in the Distributors industry. While KAVL seems to be doing ok healthwise, there are quite some concerns on its profitability. KAVL is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year KAVL has reported negative net income.

In the past year KAVL has reported a negative cash flow from operations.

KAVL had negative earnings in 4 of the past 5 years.

KAVL had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

KAVL has a worse Return On Assets (-70.26%) than 86.36% of its industry peers.

With a Return On Equity value of -80.14%, KAVL is not doing good in the industry: 77.27% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-70.26%
ROE	-80.14%
ROIC	N/A

ROA(3y)-72.37%

ROA(5y)-40.78%

ROE(3y)-93.34%

ROE(5y)-49.66%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

KAVL's Gross Margin of 231.17% is amongst the best of the industry. KAVL outperforms 100.00% of its industry peers.

KAVL's Gross Margin has improved in the last couple of years.

KAVL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	231.17%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y23.05%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KAVL does not have a ROIC to compare to the WACC, probably because it is not profitable.

KAVL has more shares outstanding than it did 1 year ago.

Compared to 5 years ago, KAVL has more shares outstanding

KAVL has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -4.41, we must say that KAVL is in the distress zone and has some risk of bankruptcy.

KAVL has a Altman-Z score of -4.41. This is amonst the worse of the industry: KAVL underperforms 81.82% of its industry peers.

There is no outstanding debt for KAVL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-4.41

ROIC/WACCN/A

WACC16.65%

2.3 Liquidity

A Current Ratio of 1.63 indicates that KAVL should not have too much problems paying its short term obligations.

KAVL's Current ratio of 1.63 is in line compared to the rest of the industry. KAVL outperforms 50.00% of its industry peers.

KAVL has a Quick Ratio of 1.63. This is a normal value and indicates that KAVL is financially healthy and should not expect problems in meeting its short term obligations.

Looking at the Quick ratio, with a value of 1.63, KAVL is in the better half of the industry, outperforming 72.73% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.63
Quick Ratio	1.63

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 66.92% over the past year.

Looking at the last year, KAVL shows a very negative growth in Revenue. The Revenue has decreased by -88.85% in the last year.

Measured over the past years, KAVL shows a very negative growth in Revenue. The Revenue has been decreasing by -51.07% on average per year.

EPS 1Y (TTM)66.92%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87.59%

Revenue 1Y (TTM)-88.85%

Revenue growth 3Y-51.07%

Revenue growth 5YN/A

Sales Q2Q%-80.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KAVL. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

KAVL does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KAIVAL BRANDS INNOVATIONS GR

NASDAQ:KAVL (10/17/2025, 12:22:29 PM)

0.6

+0.01 (+1.69%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustryDistributors

Earnings (Last)09-16 2025-09-16

Earnings (Next)02-09 2026-02-09

Inst Owners1.15%

Inst Owner Change0%

Ins Owners20.19%

Ins Owner Change0%

Market Cap6.92M

Analysts82.86

Price TargetN/A

Short Float %0.16%

Short Ratio0

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	6.14
P/FCF	N/A
P/OCF	N/A
P/B	0.69
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-0.86

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.24

FCFYN/A

OCF(TTM)-0.24

OCFYN/A

SpS0.1

BVpS0.87

TBVpS0

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-70.26%
ROE	-80.14%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	231.17%
FCFM	N/A

ROA(3y)-72.37%

ROA(5y)-40.78%

ROE(3y)-93.34%

ROE(5y)-49.66%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y23.05%

GM growth 5YN/A

F-Score3

Asset Turnover0.1

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.63
Quick Ratio	1.63
Altman-Z	-4.41

F-Score3

WACC16.65%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)66.92%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%87.59%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-88.85%

Revenue growth 3Y-51.07%

Revenue growth 5YN/A

Sales Q2Q%-80.05%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-12.58%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-9.1%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-9.25%

OCF growth 3YN/A

OCF growth 5YN/A

KAIVAL BRANDS INNOVATIONS GR (KAVL) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens